Global Wearable Injectors Market Comprehensive Study: Forecasted Market Size And Growth Rate | Amgen Inc., Becton Dickinson and Company (BD), Enable Injections LLC, Insulet Corporation, Ypsomed Holding AG, Medtronic MiniMed Inc., Tandem Diabetes Care Inc.

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Wearable Injectors Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The wearable injectors market size has grown rapidly in recent years. It will grow from $8.04 billion in 2023 to $9.07 billion in 2024 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to chronic disease management, patient convenience, technological advancements, aging population.

The wearable injectors market size is expected to see rapid growth in the next few years. It will grow to $15.23 billion in 2028 at a compound annual growth rate (CAGR) of 13.8%. The growth in the forecast period can be attributed to personalized medicine, remote patient monitoring, drug development, chronic disease management. Major trends in the forecast period include biologics and large molecules, dual-chamber wearables, connected and smart devices, patch pump technology.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=3308&type=smp

Market Segmentation:
The main types of wearable injectors are on-body injectors and off-body injectors. On-body injectors are drug delivery devices that are applied directly to the patient's skin, in the abdominal region or the back of the patient's arm. The various applications include immuno-oncology, diabetes, cardiovascular diseases, and others that are used by various end-users such as hospitals, clinics, and home care settings.

Major Driver - Surge In Diabetic And Chronic Disease Patients Fuels Growth Of The Wearable Injectors Market
The rise in the number of diabetic and chronic diseases patients such as cardiovascular diseases and cancers contributed to the growth of the wearable injectors market. According to the International Diabetes Federation, in 2021, approximately 537 million adults were living with diabetes, and by 2045, it is estimated that around 783 million adults around the world and 1 in 5 adults who are above 65 are expected to suffer from diabetes. The rise in the number of diabetes and chronic diseases patients increased the demand for the treatment of the diseases, thereby driving the wearable injectors market growth.

Competitive Landscape:
Major companies operating in the wearable injectors market include Amgen Inc., Becton Dickinson and Company (BD), Enable Injections LLC, Insulet Corporation, Ypsomed Holding AG, Medtronic MiniMed Inc., Tandem Diabetes Care Inc., Valeritas Inc., West Pharmaceutical Services Inc., Sensile Medical AG, Gerresheimer AG, Dexcom Inc., Consort Medical plc, United Therapeutics Corporation, Bühler Motor GmbH, Debiotech SA, Cellnovo Group, EoFlow Co. Ltd., CeQur SA, Haselmeier AG, Johnson & Johnson, kaleo Inc., Mylan N.V., Nemera Development S.A., F. Hoffmann-La Roche Ltd, Zosano Pharma Corporation

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/wearable-injectors-global-market-report

Top Trend - Rising Trend Of Mergers And Acquisitions In The Wearable Injectors Manufacturing Market
The focus areas for many companies in the wearable injectors manufacturing market have shifted to increasing mergers and acquisitions to acquire more production capabilities. Large prime manufacturers are forming joint ventures or buying small or midsized companies to acquire new capabilities or gain access to new markets. In February 2021, Phillips-Medisize, a US-based medical device company, collaborated with Subcuject to develop a wearable osmotic bolus injector. The collaboration aims to combine Phillips-Medisize's expertise in proprietary device platforms with Subcuject's technology innovation and drug delivery experience to accelerate the development and commercialization of the wearable osmotic bolus injector. Subcuject is a US-based medical device company that specializes in the development of a subcutaneous wearable bolus injector.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Wearable Injectors Market Characteristics
3. Wearable Injectors Market Trends And Strategies
4. Wearable Injectors Market - Macro Economic Scenario
5. Wearable Injectors Market Size And Growth
…..
27. Wearable Injectors Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.